Status:

WITHDRAWN

Study Evaluating The Effect Of A High-Fat Meal On The Pharmacokinetics Of Neratinib

Lead Sponsor:

Puma Biotechnology, Inc.

Conditions:

Healthy

Eligibility:

All Genders

18-50 years

Phase:

PHASE1

Brief Summary

This study is being conducted to see if neratinib is absorbed, distributed, or eliminated differently when administered in the fasting state versus after a high-fat meal.

Eligibility Criteria

Inclusion

  • Healthy men and women of nonchildbearing potential, age 18 to 50 years.

Exclusion

  • Any previous or current clinically significant medical condition or disease.

Key Trial Info

Start Date :

August 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2012

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00932464

Start Date

August 1 2012

End Date

August 1 2012

Last Update

May 14 2012

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.